South Korean vaccine and biotech company SK Bioscience's (KRX:302440) Germany-based CDMO subsidiary IDT Biologika is ramping up its global outreach through major industry events.
The company recently highlighted its end-to-end services in viral vaccines, gene and immune therapeutics, and aseptic injectables at the BioProcess International Europe (BPI Europe) in Hamburg, SK Bioscience said Tuesday.
Shares of SK Bioscience rose nearly 2% in recent trade on Thursday.